January 2008
Patents and Trademarks
Exiqon, AQ-Link, LNA, miRCURY, ProbeLibrary, ProbeFinder and Genoview are registered trademarks of Exiqon A/S, Vedbaek, Denmark.
Anthraquinone photochemistry products (AQ products) are covered by patents controlled by Exiqon A/S.
Locked Nucleic Acids are covered by patents and patent applications owned by Exiqon A/S.
Disclaimers
Exiqon Products: Products are for research use only and not for diagnostic or therapeutic use. The products may be used only for the buyer's internal research purposes and not for commercial use. The buyer may not resell products in their original or any modified form. The purchase of products does not include or carry an implied right or licence for the buyer to use such products in the provision of services to third parties and a license must be obtained directly from Exiqon A/S for such use.
Prespotted arrays: This product and its use are covered by one or more of the following patents owned by Oxford Gene Technology Limited or Oxford Gene Technology IP Limited: US 6,054,270, US 5,700,637, EP 0,373,203; Jap. 3,393, 528 and 3,386,391 and pending patents. The purchaser is licensed to practice methods and processes covered by these patents using this product for its own internal research purposes only but may not: transfer data derived from the use of this product to third parties for value; use this product in the provision of services to third parties for value; use this product to make, have made, create or contribute to the creation of stand alone expression database products for license, sale or other transfer to a third party for value; or use this product for the identification of antisense reagents or the empirical design of probes or sets of probes for using or making nucleic acid arrays.
Capture probe oligonucleotide sets: Exiqon A/S is not licensed under any patents owned by Oxford Gene Technology Limited or related companies (»OGT«) and cannot pass any such license to its customers. A license under OGT's patents may be necessary to manufacture or use oligonucleotide arrays. To enquire about a license under OGT's oligonucleotide array patents, please contact
licensing@ogt.co.uk.
PCR: PCR is covered by patents owned by Roche Inc. Use of the PCR process requires a license. The use of certain probes in 5'nuclease assays is covered by European patent EP-B1-0543942 and corresponding patents. The purchase of this product does not provide a license to use the patented technology described in the above-mentioned patent. A license to practice this technology for research applications must be obtained by the end-user from the company entitled to grant licenses under this patent.
DIG: DIG is licensed from Roche Diagnostics GmbH.
Specifications in this document are subject to change without notice.
